Variant report
Variant | esv3346843 |
---|---|
Chromosome Location | chr8:20721672-20724120 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs374456782 | chr8:20721673-20721674 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs114505070 | chr8:20721685-20721686 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs571741808 | chr8:20721688-20721689 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs13277522 | chr8:20721706-20721707 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs149963264 | chr8:20721715-20721716 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs7462668 | chr8:20721748-20721749 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs184706824 | chr8:20721797-20721798 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs559168429 | chr8:20721803-20721804 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs144976095 | chr8:20721807-20721808 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs571383328 | chr8:20721864-20721865 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs573074570 | chr8:20721902-20721903 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs540849719 | chr8:20721928-20721929 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs559171824 | chr8:20721936-20721937 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs577710612 | chr8:20721937-20721938 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs544678279 | chr8:20721939-20721940 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs201564510 | chr8:20721953-20721954 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs563250350 | chr8:20721972-20721973 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs530528623 | chr8:20721980-20721981 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs540069261 | chr8:20723010-20723011 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs532224251 | chr8:20723012-20723013 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs551026193 | chr8:20723035-20723036 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs78695346 | chr8:20723061-20723062 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs564772003 | chr8:20723062-20723063 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs532154215 | chr8:20723090-20723091 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs566823559 | chr8:20723190-20723191 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs534460890 | chr8:20723191-20723192 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs141259118 | chr8:20723239-20723240 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs577331863 | chr8:20723256-20723257 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs538075020 | chr8:20723329-20723330 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs146927663 | chr8:20723336-20723337 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs575443455 | chr8:20723345-20723346 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs562631220 | chr8:20723380-20723381 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs529751563 | chr8:20723389-20723390 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs547924536 | chr8:20723404-20723405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs542635122 | chr8:20723412-20723413 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs369289170 | chr8:20723421-20723422 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs73668250 | chr8:20723478-20723479 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs540479467 | chr8:20723479-20723480 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs191649126 | chr8:20723487-20723488 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs74492280 | chr8:20723493-20723494 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs7838477 | chr8:20723510-20723511 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs62496935 | chr8:20723517-20723518 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs184239845 | chr8:20723545-20723546 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs530990861 | chr8:20723571-20723572 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs566820489 | chr8:20723626-20723627 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs527698154 | chr8:20723636-20723637 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs137927491 | chr8:20723685-20723686 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs368917235 | chr8:20723699-20723700 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs190140296 | chr8:20723717-20723718 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs538416946 | chr8:20723741-20723742 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Prostate cancer | 21965145 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Lung cancer | 18438408 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Immune disease | 21572526 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Kallmann Syndrome 2 | 22470819 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Epilepsy | 22083797 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Bladder cancer | 21909424 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21364760 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cancer | 18840272 | CNVD |
Breast cancer | 19602461 | CNVD |
Osteosarcoma | 19286668 | CNVD |
Prostate cancer | 19242612 | CNVD |
Prostate cancer | 19258508 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Melanoma | 20688739 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:20721600-20722000 | Enhancers | Rectal Mucosa Donor 29 | rectum |
2 | chr8:20721600-20722000 | Enhancers | Rectal Mucosa Donor 31 | rectum |
3 | chr8:20721800-20722000 | Enhancers | Sigmoid Colon | Sigmoid Colon |
4 | chr8:20723000-20724800 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
5 | chr8:20723200-20725000 | Enhancers | NH-A | brain |
6 | chr8:20723200-20725800 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
7 | chr8:20723400-20724600 | Enhancers | HSMM | muscle |
8 | chr8:20723400-20724800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
9 | chr8:20723400-20724800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
10 | chr8:20723600-20724200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
11 | chr8:20723600-20724800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
12 | chr8:20723800-20724600 | Enhancers | HSMMtube | muscle |
13 | chr8:20723800-20725400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
14 | chr8:20724000-20724200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
15 | chr8:20724000-20724600 | Enhancers | Brain Anterior Caudate | brain |
16 | chr8:20724000-20725200 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
17 | chr8:20724000-20725200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
18 | chr8:20724000-20725400 | Enhancers | HUES48 Cell Line | embryonic stem cell |